Compagnie Lombard Odier SCmA’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-500
| Closed | -$6K | – | 557 |
|
|
2020
Q2 | $6K | Hold |
500
| – | – | ﹤0.01% | 484 |
|
|
2020
Q1 | $7K | Hold |
500
| – | – | ﹤0.01% | 446 |
|
|
2019
Q4 | $14K | Hold |
500
| – | – | ﹤0.01% | 424 |
|
|
2019
Q3 | $14K | Hold |
500
| – | – | ﹤0.01% | 429 |
|
|
2019
Q2 | $14K | Hold |
500
| – | – | ﹤0.01% | 433 |
|
|
2019
Q1 | $17K | Buy |
+500
| New | +$17K | ﹤0.01% | 465 |
|
|
2016
Q2 | – | Sell |
-100
| Closed | -$4K | – | 937 |
|
|
2016
Q1 | $4K | Buy |
+100
| New | +$4K | ﹤0.01% | 928 |
|
|
2015
Q4 | – | Sell |
-4,000
| Closed | -$150K | – | 942 |
|
|
2015
Q3 | $150K | Hold |
4,000
| – | – | 0.01% | 456 |
|
|
2015
Q2 | $136K | Hold |
4,000
| – | – | 0.01% | 502 |
|
|
2015
Q1 | $142K | Buy |
4,000
+1,000
| +33% | +$35.5K | 0.01% | 571 |
|
|
2014
Q4 | $102K | Buy |
3,000
+1,000
| +50% | +$34K | ﹤0.01% | 546 |
|
|
2014
Q3 | $77K | Hold |
2,000
| – | – | ﹤0.01% | 678 |
|
|
2014
Q2 | $78K | Hold |
2,000
| – | – | ﹤0.01% | 698 |
|
|
2014
Q1 | $68K | Buy |
2,000
+940
| +89% | +$32K | ﹤0.01% | 693 |
|
|
2013
Q4 | $22K | Buy |
+1,060
| New | +$22K | ﹤0.01% | 774 |
|